FOXP3 and nasopharyngeal carcinoma: When we compared the expression of all immunologic markers (Fig. 1) in the tumour microenvironment between primary and recurrent NPC, we found significant differences in the mean percentages of Galectin-9+ tumour cells, Foxp3+ lymphocytes and CD8+ lymphocytes.